Stryde Research will attend the Global Site Solutions Summit in Orlando, Florida, from October 15 to 18, 2026. Dr. Haein Kim and Edward Olko from our team will be there to meet with sponsors and CROs who are planning site selection or managing studies that are behind on enrolment.
Stryde runs clinical research sites inside independent specialty practices for various conditions.
Event details
- Event: Global Site Solutions Summit 2026
- Dates: Thursday, October 15, to Sunday, October 18, 2026
- Location: Signia by Hilton Orlando Bonnet Creek, Orlando, Florida
- Host: Society for Clinical Research Sites (SCRS)
- Stryde attendees: Edward Olko, Head of Business Development, and Dr. Haein Kim, Business Development Officer, Clinical Partnerships
The full agenda, session times, and hotel booking are on the Global Site Solutions Summit event page.
What is the Global Site Solutions Summit?
The Global Site Solutions Summit is the Society for Clinical Research Sites (SCRS) annual meeting for sites, sponsors, CROs, and solution providers. Its focus is site sustainability: what makes studies run well at the site level, and how sponsors and sites can work together to get there.
SCRS lists about 1,900 attendees, 200+ expert speakers, and 950 organizations at the summit.
Who from Stryde will be there?
Edward Olko, Head of Business Development, and Dr. Haein Kim, Business Development Officer for Clinical Partnerships, will represent Stryde for all four days of the summit. Between them, they handle how sponsors and CROs start working with Stryde, from the first feasibility request to placing a study at the right sites in our network.
Sponsors and CROs can book time with them before the event by emailing trials@stryderesearch.com or reaching out here.
What does Stryde do differently?
Most research sites are standalone centers that have to recruit patients. Stryde’s sites are embedded inside specialty practices where eligible patients already receive care, and the physician running the study is often the patient’s own doctor. Eligibility information is already in the chart, and patients hear about a study from someone they already trust.
Stryde has 20+ embedded sites across Dallas-Fort Worth, Houston, Louisiana, and the New York/New Jersey metro area. Those sites reach 1.5M+ patients through 100+ specialty clinics.
What should sponsors ask us?
Here’s what you might want to know:
- Feasibility: Every feasibility request receives a preliminary answer within 48 hours, guaranteed. We check against the actual practice population, and if the volume isn’t there, we say so.
- Enrollment rescue: If a study is already behind on enrollment, our embedded sites can add enrollment capacity from patient populations that are already under care.
- Quality and oversight: Stryde has an in-house medical monitor and NIH IBC-RMS approval for cell and gene therapy studies. Our quality composite scores are above 90%.
How can I meet the Stryde team in Orlando?
Email trials@stryderesearch.com to set up a meeting with Ed or Haein during the summit, October 15 to 18. We’ll find a time that works around your session schedule.